-
Share
09/02/06
23:45
Share
re: re:relenza production
Here are my roughly numbers of where the sales volume will end up, therefore dictating how much has to be produced.
(A) For Initial Pandemic Stockpiling (not replacement)
US World
Population (current) 298072289 6496635063
Coverage Factor 0.2 0.1
Population Coverage 59614458 649663506
Relenza (20%) 11922892 129932701
Cost per Unit 20 20
Gross Sales 238457831 2598654025
7% Royalty 16692048 181905782
(B) For Seasonal Flu: Relenza sales = Tamiflu sales X 0.2
(without a marketing budget from Glaxo, Relenza will ride on the back of Tamiflu)
Which ever way you look at it, its substantially highly than 15 million.
-